Brazil study suggests AstraZeneca vaccine is effective against Brazil COVID-19 variant


FILE PHOTO: Empty vials of AstraZeneca COVID-19 vaccine are seen in a tray during a mass vaccination campaign at Atletico Madrid's Wanda Metropolitano stadium in Madrid, Spain, February 25, 2021. REUTERS/Sergio Perez/File Photo

RIO DE JANEIRO (Reuters) - Preliminary studies suggest the AstraZeneca vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil's Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday.

The Brazil variant is worrying experts because it is highly contagious and has led several countries to ban travel from the Latin American nation.

(Reporting by Rodrigo Viga)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
   

Next In World

New UK challenge trial studies if people can catch coronavirus again
Venezuela makes second COVAX payment for vaccines as UN official visits
Airports get busy as Australia-New Zealand quarantine-free travel begins
Investor group calls for banks to set tougher climate targets
Exclusive: India may build new coal plants due to low cost despite climate change
Exclusive-Canada's Ontario to expand use of AstraZeneca COVID vaccine as epidemic rages
Cuban dissidents decry harassment, as congress denounces 'counterrevolution' attempts
Canada's Trudeau mobilizes federal workers to battle COVID-19 in Toronto and rest of Ontario
Malawi fires labour minister, arrests officials over misuse of COVID funds
Tunisian president draws security powers into dispute with PM

Stories You'll Enjoy


Vouchers